Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Apr;144(4):796–806.

Mice with hemangiomas induced by transgenic endothelial cells. A model for the Kasabach-Merritt syndrome.

N Dubois-Stringfellow 1, L Kolpack-Martindale 1, V L Bautch 1, R G Azizkhan 1
PMCID: PMC1887230  PMID: 8160778

Abstract

Inoculation of an established endothelial cell line from transgenic mouse hemangiomas (Py-4-1) into histocompatible mice induced vascular tumor formation at the site of infection with 100% frequency. Histological and hematological studies revealed that the mice developed hemangiomas with hematological changes similar to those found in the Kasabach-Merritt syndrome in humans, including hemolytic anemia and thrombocytopenic purpura. Modifications in the red blood cell count, hemoglobin concentration, hematocrit, and platelet count were directly correlated with the size of the hemangioma. Thus transgenic endothelial cell injection into histocompatible mice provides an in vivo model system to study the pathobiology of hemangiomas as well as the investigation of angiogenesis inhibitors.

Full text

PDF

Images in this article

798Figure 1
on p.798
799Figure 2
on p.799
800Figure 3
on p.800
801Figure 4
on p.801
802Figure 5
on p.802
804Figure 7
on p.804
805Figure 8
on p.805

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aylett S. E., Williams A. F., Bevan D. H., Holmes S. J. The Kasabach-Merritt syndrome: treatment with intermittent pneumatic compression. Arch Dis Child. 1990 Jul;65(7):790–791. doi: 10.1136/adc.65.7.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bautch V. L., Toda S., Hassell J. A., Hanahan D. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell. 1987 Nov 20;51(4):529–537. doi: 10.1016/0092-8674(87)90122-x. [DOI] [PubMed] [Google Scholar]
  3. Donald D., Dawson A. A. Microangiopathic haemolytic anaemia associated with malignant haemangio-endothelioma. J Clin Pathol. 1971 Jul;24(5):456–459. doi: 10.1136/jcp.24.5.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dubois N. A., Kolpack L. C., Wang R., Azizkhan R. G., Bautch V. L. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp Cell Res. 1991 Oct;196(2):302–313. doi: 10.1016/0014-4827(91)90265-v. [DOI] [PubMed] [Google Scholar]
  5. Enjolras O., Riche M. C., Merland J. J., Escande J. P. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990 Apr;85(4):491–498. [PubMed] [Google Scholar]
  6. Esterly N. B. Kasabach-Merritt syndrome in infants. J Am Acad Dermatol. 1983 Apr;8(4):504–513. doi: 10.1016/s0190-9622(83)70056-3. [DOI] [PubMed] [Google Scholar]
  7. Ezekowitz R. A., Mulliken J. B., Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992 May 28;326(22):1456–1463. doi: 10.1056/NEJM199205283262203. [DOI] [PubMed] [Google Scholar]
  8. GOOD T. A., CARNAZZO S. F., GOOD R. A. Thrombocytopenia and giant hemangioma in infants. AMA Am J Dis Child. 1955 Sep;90(3):260–274. doi: 10.1001/archpedi.1955.04030010262003. [DOI] [PubMed] [Google Scholar]
  9. HOLMDAHL K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr. 1955 Jul;44(4):370–379. doi: 10.1111/j.1651-2227.1955.tb04151.x. [DOI] [PubMed] [Google Scholar]
  10. Hanna B. D., Bernstein M. Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. Am J Pediatr Hematol Oncol. 1989 Summer;11(2):191–195. [PubMed] [Google Scholar]
  11. Hoak J. C., Warner E. D., Cheng H. F., Fry G. L., Hankenson R. R. Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model. J Lab Clin Med. 1971 Jun;77(6):941–950. [PubMed] [Google Scholar]
  12. Katz H. P., Askin J. Multiple hemangiomata with thrombopenia. An unusual case with comments on steroid therapy. Am J Dis Child. 1968 Mar;115(3):351–357. doi: 10.1001/archpedi.1968.02100010353010. [DOI] [PubMed] [Google Scholar]
  13. Larsen E. C., Zinkham W. H., Eggleston J. C., Zitelli B. J. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics. 1987 Jun;79(6):971–980. [PubMed] [Google Scholar]
  14. Miller J. G., Orton C. I. Long term follow-up of a case of Kasabach-Merritt syndrome successfully treated with radiotherapy and corticosteroids. Br J Plast Surg. 1992 Oct;45(7):559–561. doi: 10.1016/0007-1226(92)90157-s. [DOI] [PubMed] [Google Scholar]
  15. Orchard P. J., Smith C. M., 3rd, Woods W. G., Day D. L., Dehner L. P., Shapiro R. Treatment of haemangioendotheliomas with alpha interferon. Lancet. 1989 Sep 2;2(8662):565–567. doi: 10.1016/s0140-6736(89)90694-6. [DOI] [PubMed] [Google Scholar]
  16. SUTHERLAND D. A., CLARK H. Hemangioma associated with thrombocytopenia. Report of a case and review of the literature. Am J Med. 1962 Jul;33:150–157. doi: 10.1016/0002-9343(62)90284-x. [DOI] [PubMed] [Google Scholar]
  17. Shim W. K. Hemangiomas of infancy complicated by thrombocytopenia. Am J Surg. 1968 Dec;116(6):896–906. doi: 10.1016/0002-9610(68)90462-5. [DOI] [PubMed] [Google Scholar]
  18. Shulkin B. L., Argenta L. C., Cho K. J., Castle V. P. Kasabach-Merritt syndrome: treatment with epsilon-aminocaproic acid and assessment by indium 111 platelet scintigraphy. J Pediatr. 1990 Nov;117(5):746–749. doi: 10.1016/s0022-3476(05)83334-7. [DOI] [PubMed] [Google Scholar]
  19. Stahl R. L., Henderson J. M., Hooks M. A., Martin L. G., Duncan A. Therapy of the Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid. Am J Hematol. 1991 Apr;36(4):272–274. doi: 10.1002/ajh.2830360409. [DOI] [PubMed] [Google Scholar]
  20. Tanaka K., Shimao S., Okada T., Tanaka A. Kasabach-Merritt syndrome with disseminated intravascular coagulopathy treated by exchange transfusion and surgical excision. Dermatologica. 1986;173(2):90–94. doi: 10.1159/000249225. [DOI] [PubMed] [Google Scholar]
  21. Tsujioka K., Toda K., Maruguchi Y., Miyachi Y., Imamura S. Morphological characterization of hemangiomatous tumors derived from a novel murine vascular endothelial cell line (F-2). J Dermatol. 1991 Sep;18(9):506–516. doi: 10.1111/j.1346-8138.1991.tb03124.x. [DOI] [PubMed] [Google Scholar]
  22. Watzke H. H., Linkesch W., Hay U. Giant hemangioma of the liver (Kasabach-Merritt syndrome): successful suppression of intravascular coagulation permitting surgical removal. J Clin Gastroenterol. 1989 Jun;11(3):347–350. doi: 10.1097/00004836-198906000-00022. [DOI] [PubMed] [Google Scholar]
  23. White C. W. Treatment of hemangiomatosis with recombinant interferon alfa. Semin Hematol. 1990 Jul;27(3 Suppl 4):15–22. [PubMed] [Google Scholar]
  24. White C. W., Wolf S. J., Korones D. N., Sondheimer H. M., Tosi M. F., Yu A. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr. 1991 Jan;118(1):59–66. doi: 10.1016/s0022-3476(05)81844-x. [DOI] [PubMed] [Google Scholar]
  25. de Prost Y., Teillac D., Bodemer C., Enjolras O., Nihoul-Fekete C., de Prost D. Successful treatment of Kasabach-Merritt syndrome with pentoxifylline. J Am Acad Dermatol. 1991 Nov;25(5 Pt 1):854–855. doi: 10.1016/s0190-9622(08)80985-1. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES